Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$1.19 - $1.65 $1,555 - $2,156
-1,307 Closed
0 $0
Q4 2018

Jan 25, 2019

BUY
$0.98 - $1.85 $1,280 - $2,417
1,307 New
1,307 $1,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.59B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Sawyer & Company, Inc Portfolio

Follow Sawyer & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.